Healthcare Facilities company Aster DM Healthcare announced Q1FY25 results: Revenue grew 20% YoY to Rs 1,002 crore in Q1FY25 Vs. Rs 838 crore in Q1FY24. Operating EBITDA grew 39% YoY to Rs 177 crore in Q1FY25 Vs. Rs 128 crore in Q1FY24. Operating EBITDA Margins stood at 17.7% in Q1FY25 Vs. 15.3% in Q1FY24 PBT grew by 125% YoY to Rs 123 crore in Q1FY25 Vs. Rs 54 crore in Q1FY24. Net Profit (post NCI) grew by 80% to Rs 74 crore in Q1FY25 Vs. Rs 41 crore in Q1FY24. Commenting on the performance for Q1FY25, Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “I am pleased to announce that this quarter represents a pivotal moment for Aster DM Healthcare. With the successful segregation of our GCC business, we are now a pure-play India entity, as we embark on a new journey FY25 onwards. In Q1FY25, our India business achieved 20% YoY growth delivering the highest ever revenue performance of Rs 1,002 crore, aided by an increase in bed capacity and growth in ARPOB. The Operating EBITDA grew by 39% YoY to Rs 177 crore and net profits (post NCI) grew by 80% YoY to Rs 74 crore in Q1FY25” Dr. Moopen further added, “Aster DM Healthcare continues to get prestigious recognitions at the national level. Recently, The Economic Times awarded us as the “Best Healthcare Brand of the Year-2024”. Also, Aster CMI Hospital became the first hospital in South India to receive NABH Digital Platinum Accreditation. As we progress, we are on track to reach 6,500+ beds by FY27, further strengthening our position as a leader in the healthcare sector.” Result PDF
Conference Call with Aster DM Healthcare Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Alisha Moopen and senior management team
Healtcare Services company Aster DM Healthcare announced Q4FY24 & FY24 results: Revenue: Revenue grew 24% YoY to Rs 3,699 crore in FY24 Vs. Rs 2,983 crore in FY23. Revenue grew 22% YoY to Rs 978 crore in Q4FY24 Vs. Rs 804 crore in Q4FY23. EBITDA: Operating EBITDA grew 30% YoY to Rs 620 crore in FY24 Vs. Rs 477 crore in FY23. Operating EBITDA grew 24% YoY to Rs 167 crore in Q4FY24 Vs. Rs 135 crore in Q4FY23. Profits: PBT grew by 34% YoY to Rs 281 crore in FY24 Vs. Rs 210 crore In FY23. Adjusted PAT grew by 63% YoY to Rs 240 crore In FY24 Vs. Rs 147 crore In FY23. Reported PAT grew by 28% YoY to Rs 188 crore in FY24 Vs. Rs 147 crore in FY23. Dividend: For financial year 2024, the Board recommended a 20% final dividend of Rs 2.0 /- (face value of Rs 10 each) per equity share. The dividend is subject to the approval of shareholders in the Annual General Meeting (AGM) of the Company Commenting on the update on GCC segregation and performance for Q4 and full year FY24, Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “I am pleased to announce that we have successfully completed the segregation of our India and GCC businesses, obtaining all necessary regulatory approvals and fulfilling the conditions diligently. I want to express my deepest appreciation to all our stakeholders for their support in ushering in a new era to shape Aster India's future. The segregation has allowed us to tailor our strategies to the distinct growing needs of these geographies and position us to seize the unprecedented growth opportunities in the Indian healthcare market. In FY24, our India business showcased a remarkable 24% YoY revenue growth, surging to Rs 3,699 crores, aided by an increase in bed capacity of 550+ beds and ARPOB growth of 10% in FY24. The Operating EBITDA grew by 30% YoY to Rs.620 crores, supported by the better performance of our mature hospitals delivering 22.4% Operating EBITDA margin in FY24,” Dr. Moopen further added, “I am also pleased to share that we have been conferred with the title of 'Hospital Chain of the Year' at the ET Healthcare Award and Financial Express Healthcare Awards for the year FY23-24. Additionally, Aster Medcity (Kochi) and Aster CMI (Bengaluru) are ranked among top multispecialty hospitals across India by Times of India, Outlook, Newsweek and The Week. As we progress on our journey, we are on track to add ~1700 beds to reach to 6,500+ beds by FY27 through a prudent mix of brownfield and greenfield projects which will result in our Aster Medcity and Aster CMI hospitals expanding to 950+ beds and 850+ beds respectively. This move demonstrates our unwavering dedication to reinforcing our prominent position among India's top healthcare providers. We are happy to have closed the year with Aster India leading the growth metrics across the healthcare peers in the country. We are committed to continuing on this trajectory as the company embarks on a new chapter of future growth.” Result PDF